journal article·2022-10

Ship-in-a-bottle growth of NaYF4: Yb3+/Tm3+ upconversion nanocrystals in desilicated ZSM-5 zeolite for drug release monitoring

Huazhen Liao, Song Ye, Jingxin Ding, Jianzhong Yu, Xinling Xv, Ling Pan, Peixuan Lin, Deping Wang

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Luminescence Properties of Advanced Materials · Luminescence and Fluorescent Materials · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. Mesoporous silica nanoparticles in drug delivery and biomedical applications10.1016/j.nano.2014.09.014 ↗
2. Current advances in chitosan nanoparticles based drug delivery and targeting10.15171/apb.2019.023 ↗
3. Fluorescent reporters for drug delivery monitoring10.1002/ijch.201900137 ↗
4. A signal processor made from DNA assembly and upconversion nanoparticle for pharmacokinetic study10.1016/j.nantod.2021.101352 ↗
5. Fluorescent nanoparticles of chitosan complex for real-time monitoring drug release10.1021/la200552k ↗
6. Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release10.1021/nn400199t ↗
7. Upconversion luminescent materials: advances and applications10.1021/cr400478f ↗
8. Synthesis, characterization, and in vitro toxicity evaluation of upconversion luminescence NaLuF4:Yb3+/Tm3+ nanoparticles suitable for medical applications10.1002/jccs.201900281 ↗
9. Studying the toxicity effects of coated and uncoated NaLuF4: Yb3+, Tm3+ upconversion nanoparticles on blood factors and histopathology for Balb/C mice’s tissue
10. Upconversion luminescence enhancement in NaYF4: Yb3+, Er3+ nanoparticles induced by Cd2+ tridoping10.1016/j.materresbull.2017.02.032 ↗
11. Fast synthesis of sub-10nm β-NaYF4:Yb3+, Er3+@NaYF4 core-shell upconversion nanocrystals mediated by oleate ligands10.1016/j.materresbull.2018.03.011 ↗
12. Real-time monitoring of ATP-responsive drug release using mesoporous-silica-coated multicolor upconversion nanoparticles10.1021/acsnano.5b00641 ↗
13. Facile preparation of pyrenemethyl ester-based nanovalve on mesoporous silica coated upconversion nanoparticle for NIR light-triggered drug release with potential monitoring capability10.1016/j.colsurfa.2019.02.027 ↗
14. Fibrous CaF2: Yb, Er@SiO2-PAA ‘tumor patch’ with NIR-triggered and trackable DOX release10.1016/j.matdes.2017.01.022 ↗
15. Ratiometric Monitoring of intracellular drug release by an upconversion drug delivery nanosystem10.1021/acsami.5b03204 ↗
16. A multifunctional nanocrystalline CaF2: Tm, Yb@mSiO2 system for dual-triggered and optically monitored doxorubicin delivery10.1002/ppsc.201600166 ↗
17. pH-sensitive polymer-gated multifunctional upconversion NaYF4:Yb/Er@mSiO2 nanocomposite for oral drug delivery10.1016/j.micromeso.2018.01.029 ↗
18. Applications of zeolites in biotechnology and medicine-a review10.1039/C8BM00028J ↗
19. Biomedical applications of zeolite-based materials: a review10.1016/j.msec.2020.111225 ↗
20. Preparation and characterization of novel chitosan/zeolite scaffolds for bone tissue engineering applications10.1080/00914037.2017.1309539 ↗
21. Multifunctional inorganic nanocontainers for DNA and drug delivery into living cells10.1002/chem.201403232 ↗
22. A thermoreversible antibacterial zeolite-based nanoparticles loaded hydrogel promotes diabetic wound healing via detrimental factor neutralization and ROS scavenging10.1186/s12951-021-01151-5 ↗
23. Effects of zeolite as a drug delivery system on cancer therapy: a systematic review10.3390/molecules26206196 ↗
24. Zeolites for theranostic applications10.1039/D0TB00719F ↗
25. Hollow mesoporous ZSM-5 zeolite/chitosan ellipsoids loaded with doxorubicin as pH-responsive drug delivery systems against osteosarcoma10.1039/C7TB01830D ↗
26. Preparation and characterization of nanocomposites based on different zeolite frameworks as carriers for anticancer drug: zeolite Y versus ZSM-510.1007/s00289-018-2472-1 ↗
27. Zeolite structures loading with an anticancer compound as drug delivery systems10.1021/jp3093868 ↗
28. CuO nanoparticles incorporated in hierarchical MFI zeolite as highly active electrocatalyst for non-enzymatic glucose sensing10.1016/j.colsurfb.2014.11.027 ↗
29. Rational design of a stable peroxidase mimic for colorimetric detection of H2O2 and glucose: a synergistic CeO2/zeolite Y nanocomposite10.1016/j.jcis.2018.09.101 ↗
30. ZnO supported on high-silica HZSM-5 as efficient catalysts for direct dehydrogenation of propane to propylene
31. Preparation, scale-up and application of meso-ZSM-5 zeolite by sequential desilication–dealumination10.1007/s10934-017-0391-4 ↗
32. Creation of hollow zeolite architectures by controlled desilication of A1-zoned ZSM-5 crystals10.1021/ja052592x ↗
33. Full compositional flexibility in the preparation of mesoporous MFI zeolites by desilication10.1021/jp201671s ↗
34. Desilication of ZSM-5 zeolites for mesoporosity development using microwave irradiation10.1016/j.materresbull.2014.10.058 ↗
35. Development of hierarchical and phosphorous-modified HZSM-5 zeolites by sequential alkaline/acid treatments and their catalytic performances for methanol-to-olefins10.1016/j.materresbull.2020.110958 ↗
36. Luminescence control of silver nanoclusters by tailoring extra-framework cations in FAU-Y zeolite: implications for tunable emission10.1021/acsanm.1c03106 ↗
37. Formation of luminescent silver-clusters and efficient energy transfer to Eu3+ in faujasite NaX zeolite10.1016/j.jssc.2020.121227 ↗
38. A strategy to achieve efficient dual-mode luminescence of Eu3+ in lanthanides doped multifunctional NaGdF4 nanocrystals10.1002/adma.201000128 ↗
39. Achieving high-efficiency emission depletion nanoscopy by employing cross relaxation in upconversion nanoparticles10.1038/s41467-017-01141-y ↗
40. Colloidal synthesis and blue based multicolor upconversion emissions of size and composition controlled monodisperse hexagonal NaYF4:Yb,Tm nanocrystals10.1039/b9nr00397e ↗
41. Dyer · 2005
42. Mesoporosity development in ZSM-5 zeolite upon optimized desilication conditions in alkaline medium10.1016/j.colsurfa.2004.04.012 ↗
43. A facile route to synthesize mesoporous ZSM-5 zeolite incorporating high ZnO loading in mesopores10.1016/j.micromeso.2011.12.041 ↗
44. Development of mesoporous ZSM-5 zeolite with microporosity preservation through induced desilication10.1007/s10853-020-04855-5 ↗
45. Size dependence of Si2p core-level shift at Si nanocrystal/SiO2 interfaces
46. Energy dependent XPS measurements on thin films of a poly(vinyl methyl ether)/polystyrene blend concentration profile on a nanometer resolution to understand the behavior of nanofilms10.1039/D1SM00656H ↗
47. Light-induced changes in an alkali metal atomic vapor cell coating studied by X-ray photoelectron spectroscopy10.1063/1.4819235 ↗
48. Selective Removal of silicon from zeolite frameworks using sodium carbonate10.1039/jm9940400605 ↗
49. Probing the structure of NaYF4 nanocrystals using synchrotron-based energy-dependent x-ray photoelectron spectroscopy10.1021/jp505646j ↗
50. Surface core level BE shifts for CaO(100): insights into physical origins10.1039/C9CP04847B ↗
51. Bonding and XPS chemical shifts in ZrSiO4 versus SiO2 and ZiO2: charge transfer and electrostatic effects10.1103/PhysRevB.63.125117 ↗
52. In-situ XPS study of core-levels of ZnO thin films at the interface with graphene/Cu10.3938/jkps.73.1546 ↗
53. Charge transfer effects in electrocatalytic Ni-C revealed by x-ray photoelectron spectroscopy10.1063/1.4722785 ↗
54. Preparation of organic-modified magadiite–magnetic nanocomposite particles as an effective nanohybrid drug carrier material for cancer treatment and its properties of sustained release mechanism by Korsmeyer–Peppas kinetic model10.1007/s10853-021-06181-w ↗
55. Controlled drug release characteristics and enhanced antibacterial effect of graphene nanosheets containing gentamicin sulfate10.1039/c1nr10661a ↗
56. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles10.1021/nn2033105 ↗